Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Vietnam eco-friendly graphene material processing

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Customized sports insole ODM factory Taiwan

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Custom graphene foam processing factory Taiwan

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Custom foam pillow OEM in Vietnam

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Thailand insole ODM for global brands

A tropical bee species has evolved an extra tooth for flesh-biting and a vulture-like gut, presumably due to intense competition for nectar. A little-known species of tropical bee has evolved an extra tooth for biting flesh and a gut that more closely resembles that of vultures rather than other bees. Typically, bees don’t eat meat. However, a species of stingless bee in the tropics has evolved the ability to do so, presumably due to intense competition for nectar. “These are the only bees in the world that have evolved to use food sources not produced by plants, which is a pretty remarkable change in dietary habits,” said UC Riverside entomologist Doug Yanega. Honeybees, bumblebees, and stingless bees have guts that are colonized by the same five core microbes. “Unlike humans, whose guts change with every meal, most bee species have retained these same bacteria over roughly 80 million years of evolution,” said Jessica Maccaro, a UCR entomology doctoral student. Given their radical change in food choice, a team of UCR scientists wondered whether the vulture bees’ gut bacteria differed from those of a typical vegetarian bee. They differed quite dramatically, according to a study the team published on November 23, 2021, in the American Society of Microbiologists’ journal mBio. Raw chicken baits attracting vulture bees in Costa Rica. Credit: Quinn McFrederick/UCR To track these changes, the researchers went to Costa Rica, where these bees are known to reside. They set up baits — fresh pieces of raw chicken suspended from branches and smeared with petroleum jelly to deter ants. The baits successfully attracted vulture bees and related species that opportunistically feed on meat for their protein. Normally, stingless bees have baskets on their hind legs for collecting pollen. However, the team observed carrion-feeding bees using those same structures to collect the bait. “They had little chicken baskets,” said Quinn McFrederick, a UCR entomologist. For comparison, the team also collected stingless bees that feed both on meat and flowers, and some that feed only on pollen. On analyzing the microbiomes of all three bee types, they found the most extreme changes among exclusive meat-feeders. “The vulture bee microbiome is enriched in acid-loving bacteria, which are novel bacteria that their relatives don’t have,” McFrederick said. “These bacteria are similar to ones found in actual vultures, as well as hyenas and other carrion-feeders, presumably to help protect them from pathogens that show up on carrion.” One of the bacteria present in vulture bees is Lactobacillus, which is in a lot of humans’ fermented food, like sourdough. They were also found to harbor Carnobacterium, which is associated with flesh digestion. “It’s crazy to me that a bee can eat dead bodies. We could get sick from that because of all the microbes on meat competing with each other and releasing toxins that are very bad for us,” Maccaro said. Individual from the Trigona family of stingless bees, some of which eat meat. Credit: Ricardo Ayala The researchers noted that these bees are unusual in a number of ways. “Even though they can’t sting, they’re not all defenseless, and many species are thoroughly unpleasant,” Yanega said. “They range from species that are genuinely innocuous to many that bite, to a few that produce blister-causing secretions in their jaws, causing the skin to erupt in painful sores.” In addition, though they feed on meat, their honey is reportedly still sweet and edible. “They store the meat in special chambers that are sealed off for two weeks before they access it, and these chambers are separate from where the honey is stored,” Maccaro said. The research team is planning to delve further into vulture bee microbiomes, hoping to learn about the genomes of all bacteria as well as fungi and viruses in their bodies. Ultimately, they hope to learn more about the larger role that microbes play in overall bee health. “The weird things in the world are where a lot of interesting discoveries can be found,” McFrederick said. “There’s a lot of insight there into the outcomes of natural selection.” Reference: “Why Did the Bee Eat the Chicken? Symbiont Gain, Loss, and Retention in the Vulture Bee Microbiome” by Laura L. Figueroa, Jessica J. Maccaro, Erin Krichilsky, Douglas Yanega and Quinn S. McFrederick, 23 November 2021, mBio. DOI: 10.1128/mBio.02317-21

Scientists have discovered a brain gene linked to anxiety symptoms, offering a potential new drug target. They found that a molecule, miR483-5p, suppresses another gene, Pgap2, which causes anxiety-related changes in the brain, suggesting a potential mechanism for anxiety relief. This discovery could lead to more effective treatments for anxiety disorders. An international team of scientists has identified a gene in the brain linked to anxiety symptoms, with modifications to this gene shown to reduce anxiety levels. A gene in the brain driving anxiety symptoms has been identified by an international team of scientists. Critically, modification of the gene is shown to reduce anxiety levels, offering an exciting novel drug target for anxiety disorders. The discovery, led by researchers at the Universities of Bristol and Exeter, was published on April 25 in the journal Nature Communications. Anxiety disorders are common with 1 in 4 people diagnosed with a disorder at least once in their lifetime. Severe psychological trauma can trigger genetic, biochemical, and morphological changes in neurons in the brain’s amygdala — the brain region implicated in stress-induced anxiety, leading to the onset of anxiety disorders, including panic attacks and post-traumatic stress disorder. However, the efficacy of currently available anti-anxiety drugs is low with more than half of patients not achieving remission following treatment. Limited success in developing potent anxiolytic (anti-anxiety) drugs is a result of our poor understanding of the neural circuits underlying anxiety and molecular events resulting in stress-related neuropsychiatric states. Uncovering Molecular Events Behind Anxiety In this study, scientists sought to identify the molecular events in the brain that underpin anxiety. They focused on a group of molecules, known as miRNAs in animal models. This important group of molecules, also found in the human brain, regulates multiple target proteins controlling the cellular processes in the amygdala. Following acute stress, the team found an increased amount of one type of molecule called miR483-5p in a mouse amygdala. Importantly, the team showed that increased miR483-5p suppressed the expression of another gene, Pgap2, which in turn drives changes to neuronal morphology in the brain and behavior associated with anxiety. Together, the researchers showed that miR-483-5p acts as a molecular brake that offsets stress-induced amygdala changes to promote anxiety relief. The discovery of a novel amygdala miR483-5p/Pgap2 pathway through which the brain regulates its response to stress is the first stepping stone towards the discovery of novel, more potent, and much-needed treatments for anxiety disorders that will enhance this pathway. Dr. Valentina Mosienko, one of the study’s lead authors and an MRC Fellow and Lecturer in Neuroscience in Bristol’s School of Physiology, Pharmacology and Neuroscience, said: “Stress can trigger the onset of a number of neuropsychiatric conditions that have their roots in an adverse combination of genetic and environmental factors. While low levels of stress are counterbalanced by the natural capacity of the brain to adjust, severe or prolonged traumatic experiences can overcome the protective mechanisms of stress resilience, leading to the development of pathological conditions such as depression or anxiety. “miRNAs are strategically poised to control complex neuropsychiatric conditions such as anxiety. But the molecular and cellular mechanisms they use to regulate stress resilience and susceptibility were until now, largely unknown. The miR483-5p/Pgap2 pathway we identified in this study, activation of which exerts anxiety-reducing effects, offers a huge potential for the development of anti-anxiety therapies for complex psychiatric conditions in humans.” Reference: “miR-483-5p offsets functional and behavioural effects of stress in male mice through synapse-targeted repression of Pgap2 in the basolateral amygdala” by Mariusz Mucha, Anna E. Skrzypiec, Jaison B. Kolenchery, Valentina Brambilla, Satyam Patel, Alberto Labrador-Ramos, Lucja Kudla, Kathryn Murrall, Nathan Skene, Violetta Dymicka-Piekarska, Agata Klejman, Ryszard Przewlocki, Valentina Mosienko and Robert Pawlak, 25 April 2023, Nature Communications. DOI: 10.1038/s41467-023-37688-2 The research was funded by the Medical Research Council, Academy of Medical Sciences, Leverhulme Trust, Marie Sklodowska-Curie, and the Polish National Science Centre.

The amyloid beta protein that tangles to form the hallmark Alzheimer’s brain plaques, cling to ultra-small “bowls,” called nanobowls, scientists find. They can use these nanobowls to remove the toxic amyloid aggregates and further study them. Credit: Illustration courtesy of Vrinda Sant New research shows that the protein that causes Alzheimer’s Disease’s hallmark brain plaques clings to certain bowl-shaped nanoparticles, allowing researchers to better understand the disease and potentially providing a targeted therapeutic. Scientists are still a long way from being able to treat Alzheimer’s Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study. The plaques are caused by the amyloid beta protein, which gets misshapen and tangled in the brain. To study these protein aggregates in tissue samples, researchers often have to use techniques that can further disrupt them, making it difficult to figure out what’s going on. But new research by Vrinda Sant, a graduate student, and Madhura Som, a recent PhD graduate, in the lab of Ratnesh Lal at the University of California, San Diego, provides a new technique for studying amyloid beta and could be useful in future Alzheimer’s treatments. Sant and her colleagues presented their research at the 65th Annual Meeting of the Biophysical Society. Scientists have been studying the possibility of using nanoparticles, ultra-small structures that can be coated in therapeutics, to provide targeted treatments for a number of diseases. There are several potential applications for nanoparticles, such as coating them with chemotherapy agents and targeting them to a tumor for cancer treatment without toxic side effects for the rest of the body. Sant began researching bowl-shaped nanoparticles, which she calls “nanobowls,” as a potential way to deliver treatments for Alzheimer’s Disease. Sant expected to have to coat the nanobowls in some kind of pharmaceutical in order to have them alleviate the amyloid beta protein plaques that contribute to Alzheimer’s. But the amyloid beta proteins clung to the nanobowls even when they were just coated in a lipid-polymer without pharmaceuticals added, allowing the scientists to remove the toxic protein aggregates from the cells. “We were surprised to find that the nanobowls were therapeutic themselves,” Sant says. Sant says while using nanobowls as therapeutics for Alzheimer’s Disease can be a potential application, it currently serves scientists who want to better understand the amyloid beta aggregates. In their recent research, Sant and team found that multiple forms of amyloid beta aggregates co-exist and not all forms directly convert into amyloid plaques, confirming what had been a hypothesis in the field. The research team is now working on using nanobowls to extract and further study amyloid beta protein aggregates. With amyloid beta being implicated in neurodegenerative diseases, cancer and cardiovascular conditions, nanobowls have potential for a range of diagnostics and treatments.

DVDV1551RTWW78V